The Woodlands, Texas (June 9, 2014) ― McKesson Specialty Health and The US Oncology Network today announced the appointment of Nick Loporcaro as president, McKesson Specialty Health, effective July 16. In addition, Kirk Kaminsky has been named president, The US Oncology Network and Provider Services, effective immediately.
“Nick’s breadth of knowledge, sharp business acumen and commitment to operational excellence will play an instrumental role in further growing McKesson Specialty Health,” said Paul Julian, executive vice president and group president, McKesson Corporation. “Nick and his team will continue to build upon our commitment to running a physician-focused organization, focused on empowering a vibrant, sustainable community patient care delivery system.”
Until recently, Nick served as president, McKesson Canada, where he was instrumental in evolving the organization’s strategy to support providers, hospitals and pharmacists facing a challenging regulatory environment. Over the past decade, he has demonstrated an impressive track record of success and effective leadership in Canada. He will be succeeded by Alain Champagne, senior vice president, Pharmaceutical Distribution and Operations, McKesson Canada. Nick will be based in The Woodlands, Texas.
In addition, Kirk Kaminsky was named president, The US Oncology Network and Provider Services, reporting to Nick. In this role, Kirk will be responsible for leading The US Oncology Network, its financial and operational support, and overall strategy in support of The US Oncology Network’s vision of improving patient outcomes and quality of life.
As senior vice president, McKesson Specialty Health Operations, Kirk successfully led multiple businesses serving community oncology practices, including the Onmark Select Program, group purchasing organizations and distribution services across brand, generics and oral oncolytics. He will continue to reside in The Woodlands, Texas.
About McKesson Specialty Health
McKesson Specialty Health, a division of McKesson Corporation, empowers the community patient care delivery system by helping community practices advance the science, technology and quality of care. Through innovative clinical, research, business and operational solutions, facilitated by integrated technology systems, we focus on improving the financial health of our customers so they may provide the best care to their patients. For more information, visit www.McKessonspecialtyhealth.com.
About The US Oncology Network
The US Oncology Network is one of the nation’s largest networks of integrated, community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. A physician-led organization, The US Oncology Network unites like-minded physicians and clinicians around a common vision of improving patient outcomes and quality of life. Leveraging healthcare information technology, shared best practices, evidence-based guidelines and quality measurements, physicians within The US Oncology Network are pioneering new ways to achieve this vision. The US Oncology Network is committed to strengthening patient access to integrated care in local communities across the nation, including collaboration with a variety of payers, hospitals and academic institutions. The US Oncology Network is supported by McKesson Specialty Health, a division of McKesson Corporation focused on empowering a vibrant and sustainable community patient care delivery system. For more information, visit www.usoncology.com.